HEARTBEAM, INC. Research and Development Expense
HEARTBEAM, INC. (BEAT) reported Research and Development Expense of $2.33 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- HEARTBEAM, INC. research and development expense for the quarter ending 2026-06-30 was $2.33M, a 30.01% decline year-over-year.
- HEARTBEAM, INC. research and development expense for the quarter ending 2026-03-31 was $2.37M, a 32.13% decline year-over-year.
- HEARTBEAM, INC. research and development expense for the quarter ending 2025-12-31 was $3.35M, a 16.22% increase year-over-year.
- HEARTBEAM, INC. research and development expense for the quarter ending 2025-09-30 was $3.28M, a 13.31% increase year-over-year.
- HEARTBEAM, INC. research and development expense for fiscal 2025 was $13.45M, a 21.71% increase from fiscal 2024.
- HEARTBEAM, INC. research and development expense for fiscal 2024 was $11.05M, a 62.56% increase from fiscal 2023.
- HEARTBEAM, INC. research and development expense for fiscal 2023 was $6.80M, a 19.75% increase from fiscal 2022.
- HEARTBEAM, INC. research and development expense for fiscal 2022 was $5.68M, a 2126.27% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.33M 10-Q · filed 2026-08-13 | $4.70M 10-Q · filed 2026-08-13 | $8.05M derived: sum of 3 quarters · filed 2026-08-13 | $11.33M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $2.37M 10-Q · filed 2026-05-13 | $5.72M derived: sum of 2 quarters · filed 2026-05-13 | $9.00M derived: sum of 3 quarters · filed 2026-05-13 | $12.33M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $3.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $6.63M derived: sum of 2 quarters · filed 2026-03-12 | $9.96M derived: sum of 3 quarters · filed 2026-08-13 | $13.45M 10-K · filed 2026-03-12 |
| 2025-09-30 | $3.28M 10-Q · filed 2025-11-13 | $6.60M derived: sum of 2 quarters · filed 2026-08-13 | $10.10M 10-Q · filed 2025-11-13 | $12.98M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $3.33M 10-Q · filed 2026-08-13 | $6.82M 10-Q · filed 2026-08-13 | $9.70M derived: sum of 3 quarters · filed 2026-08-13 | $12.60M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $3.49M 10-Q · filed 2026-05-13 | $6.38M derived: sum of 2 quarters · filed 2026-05-13 | $9.27M derived: sum of 3 quarters · filed 2026-05-13 | $12.12M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $5.78M derived: sum of 2 quarters · filed 2026-03-12 | $8.62M derived: sum of 3 quarters · filed 2026-03-12 | $11.05M 10-K · filed 2026-03-12 |
| 2024-09-30 | $2.89M 10-Q · filed 2025-11-13 | $5.74M derived: sum of 2 quarters · filed 2025-11-13 | $8.16M 10-Q · filed 2025-11-13 | $10.18M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $2.84M 10-Q · filed 2025-08-13 | $5.27M 10-Q · filed 2025-08-13 | $7.28M derived: sum of 3 quarters · filed 2025-08-13 | $8.90M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $2.43M 10-Q · filed 2025-05-13 | $4.44M derived: sum of 2 quarters · filed 2025-05-13 | $6.06M derived: sum of 3 quarters · filed 2025-05-13 | $7.54M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $3.63M derived: sum of 2 quarters · filed 2025-03-13 | $5.12M derived: sum of 3 quarters · filed 2025-03-13 | $6.80M 10-K · filed 2025-03-13 |
| 2023-09-30 | $1.62M 10-Q · filed 2024-11-07 | $3.11M derived: sum of 2 quarters · filed 2024-11-07 | $4.79M 10-Q · filed 2024-11-07 | $6.43M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $1.48M 10-Q · filed 2024-08-14 | $3.17M 10-Q · filed 2024-08-14 | $4.81M derived: sum of 3 quarters · filed 2024-08-14 | $6.37M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $1.68M 10-Q · filed 2024-05-09 | $3.32M derived: sum of 2 quarters · filed 2024-05-09 | $4.88M derived: sum of 3 quarters · filed 2024-05-09 | $6.63M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $3.20M derived: sum of 2 quarters · filed 2024-03-20 | $4.95M derived: sum of 3 quarters · filed 2024-03-20 | $5.68M 10-K · filed 2024-03-20 |
| 2022-09-30 | $1.56M 10-Q · filed 2023-11-14 | $3.30M derived: sum of 2 quarters · filed 2023-11-14 | $4.04M 10-Q · filed 2023-11-14 | $4.13M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $1.74M 10-Q · filed 2023-08-10 | $2.48M 10-Q · filed 2023-08-10 | $2.57M derived: sum of 3 quarters · filed 2023-08-10 | $2.68M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $734.00K 10-Q · filed 2023-05-11 | $830.00K derived: sum of 2 quarters · filed 2023-05-11 | $935.00K derived: sum of 3 quarters · filed 2023-05-11 | $960.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $201.00K derived: sum of 2 quarters · filed 2023-03-16 | $226.00K derived: sum of 3 quarters · filed 2023-03-16 | $255.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $105.00K 10-Q · filed 2022-11-10 | $130.00K derived: sum of 2 quarters · filed 2022-11-10 | $159.00K 10-Q · filed 2022-11-10 | $206.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $25.00K 10-Q · filed 2022-08-11 | $54.00K 10-Q · filed 2022-08-11 | $101.00K derived: sum of 3 quarters · filed 2022-08-11 | $158.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $29.00K 10-Q · filed 2022-05-12 | $76.00K derived: sum of 2 quarters · filed 2022-05-12 | $133.00K derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $104.00K derived: sum of 2 quarters · filed 2022-03-24 | $133.00K 10-K · filed 2022-03-24 | |
| 2020-09-30 | $57.00K 10-Q · filed 2021-12-16 | $86.00K 10-Q · filed 2021-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |